CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,038,000 | +115.4% | 69,791 | +558.0% | 0.06% | +61.8% |
| Q2 2018 | $482,000 | -1.8% | 10,606 | +14.0% | 0.03% | -15.0% |
| Q1 2018 | $491,000 | -41.2% | 9,306 | +4.4% | 0.04% | -66.7% |
| Q2 2017 | $835,000 | +27733.3% | 8,917 | +14761.7% | 0.12% | +11900.0% |
| Q4 2016 | $3,000 | -82.4% | 60 | -80.0% | 0.00% | -96.4% |
| Q4 2014 | $17,000 | +112.5% | 300 | +50.0% | 0.03% | +250.0% |
| Q2 2014 | $8,000 | – | 200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |